Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Brain Research
|
August 28, 2018
Therapeutics development for addiction: Orexin-1 receptor antagonists
David A Perrey, Yanan Zhang
ACS Chemical Neuroscience
|
November 14, 2017
Synthesis and Evaluation of Orexin-1 Receptor Antagonists with Improved Solubility and CNS Permeability
David A Perrey, Ann M Decker, Yanan Zhang
Synthesis
|
October 2, 2019
Modified synthesis of NOP receptor antagonist SB612111
David A Perrey, Jun-Xu Li, Yanan Zhang
Drug Development and Industrial Pharmacy
|
April 3, 2002
A degradation study of a series of chloromethyl and diazomethyl ketone anti-leukemic agents
Ann T Kotchevar, David A Perrey, Fatih M Uckun
Bioorganic & Medicinal Chemistry Letters
|
March 31, 2000
Cysteine chloromethyl and diazomethyl ketone derivatives with potent anti-leukemic activity
D A Perrey, R K Narla, F M Uckun
ACS Medicinal Chemistry Letters
|
June 20, 2014
Toward the Development of Bivalent Ligand Probes of Cannabinoid CB1 and Orexin OX1 Receptor Heterodimers
David A Perrey, Brian P Gilmour, Brian F Thomas, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 31, 2000
The S-alkyl chain length as a determinant of the anti-leukemic activity of cysteine chloromethyl ketone compounds
D A Perrey, M P Scannell, R K Narla, et al.
Vision Research
|
August 1, 2000
Visual perception and stimulus orientation in cattle
G Rehkämper, A Perrey, C W Werner, et al.
Bioorganic & Medicinal Chemistry
|
March 1, 1995
Synthesis of peptide analogues containing phosphonamidate methyl ester functionality: HIV-1 proteinase inhibitors possessing unique cell uptake properties
N P Camp, D A Perrey, D Kinchington, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 12, 2011
Diaryl urea analogues of SB-334867 as orexin-1 receptor antagonists
David A Perrey, Brian P Gilmour, Scott P Runyon, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Brain Research
|
August 28, 2018
Therapeutics development for addiction: Orexin-1 receptor antagonists
David A Perrey, Yanan Zhang
ACS Chemical Neuroscience
|
November 14, 2017
Synthesis and Evaluation of Orexin-1 Receptor Antagonists with Improved Solubility and CNS Permeability
David A Perrey, Ann M Decker, Yanan Zhang
Synthesis
|
October 2, 2019
Modified synthesis of NOP receptor antagonist SB612111
David A Perrey, Jun-Xu Li, Yanan Zhang
Drug Development and Industrial Pharmacy
|
April 3, 2002
A degradation study of a series of chloromethyl and diazomethyl ketone anti-leukemic agents
Ann T Kotchevar, David A Perrey, Fatih M Uckun
Bioorganic & Medicinal Chemistry Letters
|
March 31, 2000
Cysteine chloromethyl and diazomethyl ketone derivatives with potent anti-leukemic activity
D A Perrey, R K Narla, F M Uckun
ACS Medicinal Chemistry Letters
|
June 20, 2014
Toward the Development of Bivalent Ligand Probes of Cannabinoid CB1 and Orexin OX1 Receptor Heterodimers
David A Perrey, Brian P Gilmour, Brian F Thomas, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 31, 2000
The S-alkyl chain length as a determinant of the anti-leukemic activity of cysteine chloromethyl ketone compounds
D A Perrey, M P Scannell, R K Narla, et al.
Vision Research
|
August 1, 2000
Visual perception and stimulus orientation in cattle
G Rehkämper, A Perrey, C W Werner, et al.
Bioorganic & Medicinal Chemistry
|
March 1, 1995
Synthesis of peptide analogues containing phosphonamidate methyl ester functionality: HIV-1 proteinase inhibitors possessing unique cell uptake properties
N P Camp, D A Perrey, D Kinchington, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 12, 2011
Diaryl urea analogues of SB-334867 as orexin-1 receptor antagonists
David A Perrey, Brian P Gilmour, Scott P Runyon, et al.
Page
of 2